Point72 Asset Management L.P. 13D and 13G filings for Iovance Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 06:16 am Sale | 2023-12-31 | 13G | Iovance Biotherapeutics, Inc. IOVA | Point72 Asset Management L.P. | 468,821 0.200% | -7,646,069 (-94.22%) | Filing |
| 2023-02-17 4:35 pm Purchase | 2023-02-16 | 13G | Iovance Biotherapeutics, Inc. IOVA | Point72 Asset Management L.P. | 8,114,890 5.000% | 8,114,890 (New Position) | Filing |